According to a new report from Intel Market Research, the global oral anti-diabetic drug market was valued at USD 38.7 billion in 2025 and is projected to reach USD 58.9 billion by 2034, growing at a CAGR of 5.8% during the forecast period (2026-2034). This substantial growth trajectory is fueled by the rising global diabetes epidemic, therapeutic...
English
Polski
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek